| 丙酸氟替卡松鼻喷雾剂 | Haleon Denmark ApS | (1)每瓶60喷;每喷含丙酸氟替卡松50微克,药液浓度为0.05%(克/克);(2)每瓶120喷;每喷含丙酸氟替卡松50微克,药液浓度为0.05%(克/克) | Glaxo Wellcome, S.A. | 国药准字HJ20140117 | 2025-01-24 | 查看 |
| 沙美特罗替卡松吸入粉雾剂 | Neutec Ilac San. Tic. A.S. | 每泡含昔萘酸沙美特罗50μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松250μg；递送剂量为昔萘酸沙美特罗47µg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松231µg | Neutec Inhaler Ilac San. ve Tic. A.S. | 国药准字HJ20240136 | 2024-11-22 | 查看 |
| 沙美特罗替卡松吸入粉雾剂 | Neutec Ilac San. Tic. A.S. | 每泡含昔萘酸沙美特罗50μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松500μg；递送剂量为昔萘酸沙美特罗47µg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松460µg | Neutec Inhaler Ilac San. ve Tic. A.S. | 国药准字HJ20240137 | 2024-11-22 | 查看 |
| 沙美特罗替卡松吸入粉雾剂 | Laboratoire GlaxoSmithKline | 每泡含昔萘酸沙美特罗50μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松500μg，递送剂量为昔萘酸沙美特罗47μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松460μg | Glaxo Wellcome Production | 国药准字HJ20150325 | 2024-10-29 | 查看 |
| 沙美特罗替卡松吸入粉雾剂 | Laboratoire GlaxoSmithKline | 每泡含昔萘酸沙美特罗50μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松250μg，递送剂量为昔萘酸沙美特罗47μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松231μg | Glaxo Wellcome Production | 国药准字HJ20150324 | 2024-10-29 | 查看 |
| 沙美特罗替卡松吸入粉雾剂 | Laboratoire GlaxoSmithKline | 每泡含昔萘酸沙美特罗50μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松100μg，递送剂量为昔萘酸沙美特罗47μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松92μg | Glaxo Wellcome Production | 国药准字HJ20150323 | 2024-10-29 | 查看 |
| 丙酸氟替卡松吸入气雾剂 | GLAXOSMITHKLINE, S.A. | 每瓶60揿，每揿含丙酸氟替卡松125μg，递送剂量为丙酸氟替卡松110μg；每瓶120揿，每揿含丙酸氟替卡松125μg，递送剂量为丙酸氟替卡松110μg | Glaxo Wellcome SA | 国药准字HJ20130190 | 2023-12-27 | 查看 |
| 丙酸氟替卡松吸入气雾剂 | GLAXOSMITHKLINE, S.A. | 每瓶120揿，每揿含丙酸氟替卡松50μg，递送剂量为丙酸氟替卡松44μg | Glaxo Wellcome SA | 国药准字HJ20130189 | 2023-12-27 | 查看 |
| 丙酸氟替卡松乳膏 | 澳美制药厂有限公司 BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED | 0.05% [（1）5g：2.5mg；（2）10g：5mg；（3）15g：7.5mg；（4）20g： 10mg；（5）30g： 15mg ] | Bright Future Pharmaceuticals Factory | 国药准字HC20150022 | 2023-12-01 | 查看 |
| 丙酸氟替卡松乳膏 | 澳美制药厂有限公司 BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED | 0.05% [（1）5g：2.5mg；（2）10g：5mg；（3）15g：7.5mg；（4）20g： 10mg；（5）30g： 15mg ] | Bright Future Pharmaceuticals Factory | 国药准字HC20150021 | 2023-12-01 | 查看 |
| 氮䓬斯汀氟替卡松鼻喷雾剂 | Viatris Healthcare GmbH | 每瓶120喷，每喷含盐酸氮䓬斯汀137μg和丙酸氟替卡松50μg | Cipla Limited | 国药准字HJ20230090 | 2023-06-30 | 查看 |
| 丙酸氟替卡松雾化吸入用混悬液 | Eddingpharm B.V. | 2ml：0.5mg | GlaxoSmithKline Australia Pty Ltd. | 国药准字HJ20170361 | 2022-01-11 | 查看 |
